Clinical Trials Logo

Filter by:
NCT ID: NCT03432936 Active, not recruiting - Cancer Clinical Trials

Prospective Use of Philips iSuite for Interventional Procedures

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This research study is being done to look at new MRI imaging guidance software, Philips Interventional iSuite software, to see if using will improve the physician's ability to quickly place and guide needle tip position for biopsies and ablations.

NCT ID: NCT03432806 Active, not recruiting - Colon Cancer Clinical Trials

A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

Start date: November 28, 2017
Phase:
Study type: Observational

The purpose of this study is to explore novel ways of diagnosing colon cancer and predicting its propensity to spread to other organs such as the liver.

NCT ID: NCT03432520 Active, not recruiting - Hemophilia A Clinical Trials

Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A

Start date: August 14, 2018
Phase:
Study type: Observational

This long-term follow-up study will continue to evaluate the long-term safety and efficacy of SPK-8011 and SPK-8016 in males with hemophilia A, who have received a single intravenous administration of SPK-8011 or SPK-8016 in any Spark-sponsored SPK-8011 or SPK-8016 study.

NCT ID: NCT03431935 Active, not recruiting - Sickle Cell Disease Clinical Trials

Predictors and Outcomes in Patients With Sickle Cell Disease

Start date: July 31, 2018
Phase:
Study type: Observational

Children with sickle cell disease (SCD) are living longer with the advent of medical advances such as prophylactic penicillin, chronic transfusion, and hydroxyurea. Despite greater longevity in SCD, the period following the transition from pediatric to adult care is critical; youth aged 18-30 years are at high risk for mortality and have high rates of healthcare utilization, leading to high healthcare costs. As such, health care transition (HCT) programs have been created to prepare patients for adult-centered care and subsequently, improve health outcomes. However, very few programs have been evaluated for effectiveness in achieving optimal health outcomes in SCD. This paucity of program evaluation is attributed to a lack of identifiable predictors and outcomes. Researchers at St. Jude Children's Research Hospital want to identify factors and patterns of successful HCT. This information will be used to develop approaches to best evaluate HCT interventions and identify areas of improvement of HCT programming. PRIMARY OBJECTIVE: Describe hospital utilization, treatment adherence, and health-related quality of life in a cohort of patients with sickle cell disease (SCD) who will transfer to adult care during the study period. SECONDARY OBJECTIVE: Examine the associations between various factors and health care transition (HCT) outcomes.

NCT ID: NCT03431896 Active, not recruiting - Amyloidosis Clinical Trials

Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

MED-hATTR
Start date: February 1, 2018
Phase:
Study type: Observational

This study measures circulating, misfolded ATTR oligomers in asymptomatic ATTRm amyloidosis genetic carriers longitudinally over five years.

NCT ID: NCT03431350 Active, not recruiting - Clinical trials for Prostatic Neoplasms, Castration-Resistant

A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer

QUEST
Start date: March 2, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to: a) establish the recommended phase 2 dose (RP2D) and to evaluate the antitumor activity and safety of niraparib combination therapies (Combinations 1 and 2) and b) to determine the relative bioavailability of niraparib and abiraterone acetate (AA) in combination (Combination 3) in participants with metastatic castration-resistant prostate cancer (mCRPC).

NCT ID: NCT03431090 Active, not recruiting - Clinical trials for Hematologic Malignancy

Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia

Start date: March 2, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase I/II study designed to evaluate the kinetics of hematopoietic reconstitution and the incidence of acute chronic GVHD after partially matched related donor hematopoietic cell transplantation using an αβTCR/CD19+ cell depleted graft.

NCT ID: NCT03431051 Active, not recruiting - Health and Wellness Clinical Trials

The Impact of Workplace Food and Beverage Choices on Health and Wellness

Start date: January 18, 2018
Phase: N/A
Study type: Interventional

The study is designed to determine if instituting a Healthy Beverage Initiative (HBI) at hospitals influences health and wellness of employees over a 12 month period.

NCT ID: NCT03430583 Active, not recruiting - Clinical trials for Single Ventricle Heart Disease

Evaluation of Fontan-Associated Liver Disease

FALD
Start date: February 20, 2018
Phase:
Study type: Observational

A study to evaluate the efficacy of MZ101 therapy in reducing liver stiffness.

NCT ID: NCT03429946 Active, not recruiting - Healthy Clinical Trials

Hypoglycemia and Autonomic Nervous System Function-B

HypoANS-B
Start date: July 17, 2013
Phase: Phase 4
Study type: Interventional

This study tests the hypothesis that, compared to prior normal blood sugar, prior low blood sugar impairs cardiovascular autonomic function. The proposed studies will also test the hypothesis that the effects of prior low blood sugar on cardiovascular autonomic function are blocked by administration of a mineralocorticoid receptor antagonist.